Global Medical Morphine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Medical Morphine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3–7 hours. Long-acting formulations also exist.
Medical Morphine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Morphine market is projected to reach US$ 12900 million in 2034, increasing from US$ 10970 million in 2022, with the CAGR of 2.3% during the period of 2024 to 2034. Demand from Cancer and Arthritis are the major drivers for the industry.
The increasing prevalence of arthritis and cancer in geriatric patients is projected to impact the morphine market globally positively. The global medical morphine market is consolidated in nature owing to the dominance of few companies in manufacturing and processing. Morphine production is regulated by stringent regulation policies passed by several countries which would hamper its manufacturing. North America dominated the global medical morphine market and is expected to maintain its position in global market attributed to its increasing consumption in the U.S.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Morphine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Pfizer
Sun Pharmaceutical Industries
Taj Pharmaceuticals Limited
Segment by Type
Oral
Injectables
Cancer
Arthritis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Medical Morphine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Morphine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Morphine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Medical Morphine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Morphine introduction, etc. Medical Morphine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Medical Morphine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Medical Morphine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Morphine market is projected to reach US$ 12900 million in 2034, increasing from US$ 10970 million in 2022, with the CAGR of 2.3% during the period of 2024 to 2034. Demand from Cancer and Arthritis are the major drivers for the industry.
The increasing prevalence of arthritis and cancer in geriatric patients is projected to impact the morphine market globally positively. The global medical morphine market is consolidated in nature owing to the dominance of few companies in manufacturing and processing. Morphine production is regulated by stringent regulation policies passed by several countries which would hamper its manufacturing. North America dominated the global medical morphine market and is expected to maintain its position in global market attributed to its increasing consumption in the U.S.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Morphine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Pfizer
Sun Pharmaceutical Industries
Taj Pharmaceuticals Limited
Segment by Type
Oral
Injectables
Segment by Application
Cancer
Arthritis
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Medical Morphine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Morphine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Morphine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Medical Morphine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Morphine introduction, etc. Medical Morphine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Medical Morphine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices